Covered recipient · General Payments record
NISSA CHRISTINE BLOCHER
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$6,323.68
- Reported across 256 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,411.11 | 64 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $201.13 | 9 |
| Corcept Therapeutics | $166.82 | 7 |
| Lilly USA, LLC | $142.78 | 6 |
| Amphastar Pharmaceuticals, Inc. | $94.51 | 5 |
| Amgen Inc. | $90.06 | 5 |
| DEXCOM, INC. | $84.43 | 3 |
| Abbott Laboratories | $59.84 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.81 | 3 |
| MannKind Corporation | $56.34 | 3 |
| Kyowa Kirin, Inc. | $54.88 | 2 |
| Astellas Pharma US Inc | $45.05 | 2 |
| SANOFI-AVENTIS U.S. LLC | $35.68 | 2 |
| Neurocrine BioSciences, Inc. | $32.31 | 1 |
| Ascensia Diabetes Care US Inc. | $31.38 | 1 |
| Tandem Diabetes Care, Inc. | $30.64 | 1 |
| Medtronic, Inc. | $28.57 | 1 |
| Insulet Corporation | $25.60 | 1 |
| Radius Health, Inc. | $23.07 | 1 |
| Averitas Pharma Inc. | $22.67 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.37 | 1 |
| Rhythm Pharmaceuticals, Inc. | $19.91 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $19.29 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.50 | 1 |
| PFIZER INC. | $17.84 | 1 |
| Ultragenyx Pharmaceutical Inc. | $17.04 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (64)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.